Clene Inc. (CLNN): Long-Term Debt
$17.79M
As of 2025-12-31
$17.60M
As of 2026-06-30
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.79M | n/a | 2026-03-17, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| Clene Inc. (CLNN) | 2025-12-31 | $17.79M | n/a |
| Scienture Holdings, Inc. (SCNX) | 2024-12-31 | $2.90M | n/a |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $0 | n/a |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $109.59M | +6.9% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $0 | -100.0% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $34.29M | n/a |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $150.0K | 0.0% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2025-03-31 | $807.2K | +27.8% |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $60.04M | -4.2% |
Compare CLNN, SCNX, YARW, BTAIQ side by side · Screen every company in Pharmaceutical Preparations ↗